Northern Trust
TMDX icon

Northern Trust’s Transmedics TMDX Stock Holding History

Northern Trust’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5M Buy
368,860
+30,701
+9% +$2.6M ﹤0.01% 1677
2026
Q1 		$33.6M Sell
338,159
-1,057
-0.3% -$138K ﹤0.01% 1363
2025
Q4 		$41.3M Sell
339,216
-8,253
-2% -$1.04M 0.01% 1230
2025
Q3 		$39M Sell
347,469
-5,261
-1% -$616K 0.01% 1283
2025
Q2 		$47.3M Sell
352,730
-9,233
-3% -$1.01M 0.01% 1136
2025
Q1 		$24.4M Buy
361,963
+7,341
+2% +$505K ﹤0.01% 1509
2024
Q4 		$22.1M Buy
354,622
+40,093
+13% +$3.73M ﹤0.01% 1631
2024
Q3 		$49.4M Buy
314,529
+34,631
+12% +$5.34M 0.01% 1032
2024
Q2 		$42.2M Sell
279,898
-8,588
-3% -$1.03M 0.01% 1107
2024
Q1 		$21.3M Sell
288,486
-8,065
-3% -$665K ﹤0.01% 1550
2023
Q4 		$23.4M Sell
296,551
-40,680
-12% -$2.45M ﹤0.01% 1502
2023
Q3 		$18.5M Buy
337,231
+3,345
+1% +$241K ﹤0.01% 1600
2023
Q2 		$28M Buy
333,886
+16,692
+5% +$1.28M 0.01% 1368
2023
Q1 		$24M Buy
317,194
+5,559
+2% +$384K ﹤0.01% 1437
2022
Q4 		$19.2M Buy
311,635
+5,065
+2% +$269K ﹤0.01% 1555
2022
Q3 		$12.8M Buy
306,570
+28,667
+10% +$1.25M ﹤0.01% 1812
2022
Q2 		$8.74M Buy
277,903
+3,496
+1% +$93.2K ﹤0.01% 2128
2022
Q1 		$7.39M Sell
274,407
-10,433
-4% -$187K ﹤0.01% 2342
2021
Q4 		$5.46M Sell
284,840
-2,234
-0.8% -$56K ﹤0.01% 2627
2021
Q3 		$9.5M Sell
287,074
-10,403
-3% -$318K ﹤0.01% 2313
2021
Q2 		$9.87M Buy
297,477
+10,729
+4% +$297K ﹤0.01% 2369
2021
Q1 		$11.9M Sell
286,748
-35,916
-11% -$1.11M ﹤0.01% 2189
2020
Q4 		$6.42M Sell
322,664
-13,071
-4% -$193K ﹤0.01% 2531
2020
Q3 		$4.63M Buy
335,735
+68,940
+26% +$1.18M ﹤0.01% 2582
2020
Q2 		$4.78M Buy
266,795
+97,856
+58% +$1.53M ﹤0.01% 2555
2020
Q1 		$2.04M Sell
168,939
-1,579
-0.9% -$26.5K ﹤0.01% 2847
2019
Q4 		$3.24M Buy
170,518
+72,913
+75% +$1.34M ﹤0.01% 2842
2019
Q3 		$2.32M Buy
97,605
+61,333
+169% +$1.47M ﹤0.01% 3021
2019
Q2 		$1.05M Buy
+36,272
New +$990K ﹤0.01% 3344

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Northern Trust's TMDX Position: Q2 2026 in Review

Northern Trust increased its Transmedics (TMDX) stake by 9.1% in Q2 2026, buying an estimated $2.6M and bringing the position to 368,860 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Northern Trust first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $49.4M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Northern Trust held 368,860 shares of Transmedics worth $24.5M as of Q2 2026.
  • Northern Trust bought 30,701 Transmedics shares in Q2 2026, an estimated $2.6M.
  • Transmedics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1677 holding.
  • Northern Trust first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Northern Trust's Transmedics position peaked at $49.4M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.